Related Experiment Video
Updated: Jan 11, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
Paired tumor-normal sequencing provides insights into the CDKN2A-associated tumor spectrum
Kelsey E Breen1, Nikita Mehta2, Vignesh Ravichandran3
1Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Abstract:
Germline pathogenic variants (PV) in CDKN2A are characterized by an increased risk for melanoma, pancreatic cancer, nervous system tumors, and additional cancer types. We sought to define the tumor and clinical characteristics in a cohort of cancer patients with CDKN2A PV. Amongst 71,868 patients, 69 (0.1%) had a CDKN2A PV. Of these, 87.0% (n = 60), 7.2% (n = 5), and 5.8% (n = 4) had a PV impacting p16INK4A, p14ARF, or both p16INK4A and p14ARF, respectively. Biallelic inactivation of CDKN2A was observed in 33/47 (70.2%) of tumors assessed. Most tumors (28/38, 73.7%) in patients with p16INK4A PV demonstrated biallelic inactivation, including non-classic tumors such as lung cancer and osteosarcoma. Approximately half (5/9, 55.6%) of tumors in patients where p14ARF was impacted demonstrated biallelic inactivation, including peripheral nervous system tumors. This analysis supports a potential role of CDKN2A in the development of tumors beyond melanoma and pancreatic cancer and may have important implications for surveillance recommendations.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11:02Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
Published on: October 18, 2013
Related Concept Videos
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cancers Originate from Somatic Mutations in a Single Cell
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
Inhibition of Cdk Activity